Research programme: diacylglycerol transferase-1 inhibitors - Madrigal PharmaceuticalsAlternative Names: DGAT1 inhibitors - Madrigal Pharmaceuticals; RO-5131723
Latest Information Update: 30 Mar 2012
At a glance
- Originator Roche
- Developer Madrigal Pharmaceuticals; Roche
- Class Carboxylic acids
- Mechanism of Action Diacylglycerol O acyltransferase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Obesity; Type 2 diabetes mellitus